MedTrace Logo

Hativ® ELectrocardiogram Monitoring on Patients With Suspected Arrhythmia

NCT06250712 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 588

Last updated 2025-09-26

No results posted yet for this study

Summary

HELP-A study is a single-center, randomized, controlled trial. A total of 588 patients enrolled during the 2 years of enrollment period and followed for 1 month of follow-up period. This study aims to compare diagnostic yield between continuous ECG Patch and intermittent handheld ECG in patients with arrhythmia symptoms.

Conditions

Interventions

DEVICE

Continous ECG Patch

Using a continuous patch ECG for 1 week during 1 month

DEVICE

Intermittent handheld ECG

Using a handheld ECG twice daily and when symptoms are present during 1 month

Sponsors & Collaborators

  • Wonju Severance Christian Hospital

    lead OTHER

Principal Investigators

  • Young Jun Park, MD · Wonju Severance Christian Hopsital

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-02-22
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06250712 on ClinicalTrials.gov